An internet-based training program designed to enhance communication skills in C-reactive protein point of care testing may be helpful in reducing long-term antibiotic prescribing in respiratory tract infections.
The dosing recommendations regarding levofloxacin for the treatment and prevention of drug-resistant tuberculosis in children may need to be re-evaluated.
There was an increased personal risk for acquiring fluoroquinolone-resistant E coli in certain neighborhoods with higher fluoroquinolone consumption.
Pharmacometrics represents a set of tools that help streamline the development of antibacterial agents.
The Infectious Disease Society of America has published updated guidelines for the management of asymptomatic bacteriuria.
Study findings indicated that withholding antimicrobial therapy in CoNS-CRBSI is not associated with short-term complications or long-term recurrences.
Patients aged >65 years with a UTI may have an increased risk for septicemia and death within 60 days if antibiotic treatment is deferred or not prescribed.
Replacing ethambutol with moxifloxacin has not shown efficacy in tuberculosis treatment success in an 8-week trial.
3g of once-daily fosfomycin for 1 week followed by 3g every 48 h for 6 to 12 weeks is a safe and effective therapy for chronic bacterial prostatitis.
A recent report published in the American Journal of Case Reports describes a rare case of drug reaction with eosinophilia and systemic symptoms (DRESS)-induced agranulocytosis in a patient treated with the beta-lactam antibiotic oxacillin.
